Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons.

Journal of molecular neuroscience : MN | 2018

The spreading of misfolded protein species contributes to the propagation of harmful mediators in proteinopathies, including Alzheimer's disease (AD). Cellular stress circumstances, such as abnormal protein accumulation or nutrient deprivation, elicit the secretion of soluble misprocessed proteins and insoluble aggregates via multiple mechanisms of unconventional secretion. One of them consists in the rerouting of autophagic vacuoles towards exocytosis, an unconventional type of autophagy mediated by caspase-3 activation under starvation. Ischemic injury is a starvation condition characterized by oxygen/nutrient deprivation, whose contribution in AD onset has definitely been endorsed. Thus, we investigated the effect of oxygen-glucose deprivation (OGD), an experimental condition mimicking cerebral ischemia, in search of alteration in Tau processing and secretion in hippocampal neurons primary cultures. Our results showed that OGD caused alterations in Tau phosphorylation and processing, paralleled by an induction of its secretion. Interestingly, together with caspase-3 activation, full-length (FL) and fragmented Tau forms were secreted by their own or through a heterogeneous population of microvesicles (MVs), including autophagosome marker LC3-positive vesicles. Accordingly, confocal microscopy revealed a partial colocalization of intracellular Tau and LC3. Summarizing, our findings indicate that OGD alters Tau intracellular levels and protein processing. Consequently, Tau clearance was stimulated through multiple mechanisms related to unconventional Tau secretion, including exophagy. However, the activation of this response represent a double edge sword, because it could contribute to the spreading of misfolded Tau, a neurodegeneration pathway in AD and other tauopathies.

Pubmed ID: 30421280 RIS Download

Additional research tools detected in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


SQSTM1/p62 Antibody (antibody)

RRID:AB_10624872

This polyclonal targets SQSTM1/p62

View all literature mentions

Phospho-GSK-3 (Ser9) Antibody (antibody)

RRID:AB_331405

This polyclonal targets Phospho-GSK-3 (Ser9)

View all literature mentions

PARP antibody [E102] (antibody)

RRID:AB_777101

This monoclonal targets PARP

View all literature mentions

Beclin-1 Antibody (antibody)

RRID:AB_490837

This polyclonal targets Beclin-1

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_915950

This polyclonal targets LC3B

View all literature mentions

Mouse Anti-GSK3beta Monoclonal Antibodies, Unconjugated Clone ZG004 (antibody)

RRID:AB_10373422

This monoclonal targets Mouse GSK3beta Antibodies Clone ZG004

View all literature mentions

Caspase-3 (8G10) Rabbit mAb (antibody)

RRID:AB_2069872

This monoclonal targets Caspase-3 (8G10) Rabbit mAb

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_915950

This polyclonal targets LC3B

View all literature mentions

SQSTM1/p62 Antibody (antibody)

RRID:AB_10624872

This polyclonal targets SQSTM1/p62

View all literature mentions

Caspase-3 (8G10) Rabbit mAb (antibody)

RRID:AB_2069872

This monoclonal targets Caspase-3 (8G10) Rabbit mAb

View all literature mentions

Phospho-GSK-3 (Ser9) Antibody (antibody)

RRID:AB_331405

This polyclonal targets Phospho-GSK-3 (Ser9)

View all literature mentions

PARP antibody [E102] (antibody)

RRID:AB_777101

This monoclonal targets PARP

View all literature mentions

Beclin-1 Antibody (antibody)

RRID:AB_490837

This polyclonal targets Beclin-1

View all literature mentions

Mouse Anti-GSK3beta Monoclonal Antibodies, Unconjugated Clone ZG004 (antibody)

RRID:AB_10373422

This monoclonal targets Mouse GSK3beta Antibodies Clone ZG004

View all literature mentions